Loading...
Dernières publications
-
Luce Barbat Du Closel, Nathalie Bonello-Palot, Yann Pereon, Andoni Echaniz-Laguna, Jean Philippe Camdessanche, et al.. Clinical and electrophysiological characteristics of women with X-linked Charcot-Marie-Tooth disease. European Journal of Neurology, 2023, 30 (10), pp.3265-3276. ⟨10.1111/ene.15937⟩. ⟨hal-04254200⟩
-
Corinna Preuße, Barbara Paesler, Christopher Nelke, Derya Cengiz, Thomas Müntefering, et al.. Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositis. Acta Neuropathologica, 2022, 144 (2), pp.353-372. ⟨10.1007/s00401-022-02438-z⟩. ⟨hal-03830925⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-03832478⟩
-
Lee Nguyen, Marie Bretagne, Jennifer Arrondeau, Noel Zahr, Stephane Ederhy, et al.. Reversal of immune-checkpoint inhibitor fulminant myocarditis using personalized-dose-adjusted abatacept and ruxolitinib: proof of concept. Journal for Immunotherapy of Cancer, 2022, 10 (4), pp.e004699. ⟨10.1136/jitc-2022-004699⟩. ⟨hal-04002766⟩
-
Stéphane Ederhy, Perrine Devos, Bruno Pinna, Elisa Funck-Brentano, Baptiste Abbar, et al.. 8 F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography imaging for the diagnosis of immune checkpoint inhibitors associated myocarditis. Archives of cardiovascular diseases, 2022, ⟨10.1016/j.acvd.2021.12.001⟩. ⟨hal-03561783⟩
-
Pierre Bay, Marc Pineton de Chambrun, Vincent Rothstein, Matthieu Mahevas, Nicolas de Prost, et al.. Plasma exchange are not associated with better outcome in MDA5 rapidly-progressive interstitial lung disease. French Intensive Care Society International Congress 2022, 2022, paris, France. pp.54, ⟨10.1186/s13613-022-01016-6⟩. ⟨hal-03831253⟩
-
Franck Phan, Samia Boussouar, Olivier Lucidarme, Mohamed Zarai, Joe-Elie Salem, et al.. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients. Cardiovascular Diabetology, 2021, 20, pp.165. ⟨10.1186/s12933-021-01327-1⟩. ⟨hal-03346419⟩
Chiffres clés
121
Publications avec texte intégral
Open Access
53 %
Mots clés
Biomarker
Biomarqueurs
Antisynthetase
Inflammation
Auto‐antibodies
B cell homeostasis
Adult
Aldosterone
Idiopathic inflammatory myopathies
Interstitial lung disease
COVID-19
Anticorps anti-agalsidase
Myositis
Cancer
Aldostérone
Antibodies
Female
AAV vector
Anti-drug antibodies
AAV vectors
Anti-agalsidase antibodies
Sphingosine-1-phosphate
Polymyositis
Dermatomyositis
Anti-IgE IgG
Antisynthetase syndrome
Inclusion body myositis
Immune checkpoint inhibitors
Myopathy
Anti-Mi2
Bioelectrical impedance analysis
Autoimmune diseases
Anémie hémolytique
Prognosis
Autoantibodies
Adeno-associated virus
Dependovirus/genetics/immunology
CD8+T cells
Inflammatory myopathy
Animals
Biopsy
Myocarditis
Adolescence
Autoantibody
Case reports
Outcome measures
Multidisciplinarity
Inborn errors of metabolism
Anticorps spécifique des myosites
Anti-interleukin-6
Amyotrophy
Adeno-associated vector
B-lymphocyte
Acid-alpha-glucosidase
Muscle
Systems biology
AAV antibody
Gene therapy
Active
Agalsidase
Cytokines
Assisted communication devices
Middle Aged
Autoimmunity
Auto-antibodies
Acute Kidney Injury/epidemiology/etiology
Interferon
CD8+ T-bet+ cells
Adjudication
Auto-immunité
IBM
Antiphospholipid syndrome
Adeno-associated virus vector
Humans
Immunotherapy
AAV
Myositis and muscle disease
Analyses multidimensionnelles
Lysosomal storage diseases
Adverse drug reactions
Anti-synthetase syndrome
Abnormal movement
Mass cytometry
Aged
Male
AAV humoral immunity
Skeletal muscle
Data integration
Antisynthétase
Anti‐mitochondrial antibodies
Amyotrophic lateral sclerosis
Anti-MDA5 autoantibodies
DM
Deep immune profiling
Machine learning
IMNM
Fabry disease
Biomarkers
Arthritis
Antibody responses